Proceedings from a CME symposium held at the 2020 Genitourinary
Cancers Symposium. Featuring perspectives from Drs Peter H
O’Donnell, Daniel P Petrylak, Elizabeth R Plimack, Jonathan E
Rosenberg and Guru Sonpavde.
Introduction
Program Overview: Dr Neil Love (00:00)
Immune Checkpoint Inhibitors for Patients with
Nonmetastatic Urothelial Bladder Cancer (UBC)
Roundtable Discussion (1:05)
Faculty Presentation — Dr
Plimack (13:05)
Role of Anti-PD-1/PD-L1 Antibodies in the Up-Front
Management of Advanced UBC
Roundtable Discussion (25:17)
Faculty Presentation — Dr Rosenberg (39:50)
Application of Anti-PD-1/PD-L1 Antibodies for
Progressive Metastatic Disease; Ongoing Investigation of Immune
Checkpoint Inhibitors in Advanced UBC
Roundtable Discussion (54:11)
Faculty Presentation — Dr O’Donnell (1:02:25)
Approved and Investigational Antibody-Drug Conjugates
for Advanced UBC
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.